TORONTO, Feb. 1 /CNW/ - Biosign Technologies Inc. (TSXV: BIO, "Biosign")
announces the formal appointment of Scott Worthington as Chief
Mr. Worthington has over 30 years of senior financial and executive
management experience, including 9 years at Dell Computer Corporation,
where he held numerous positions including Chief Financial Officer of
the Canadian subsidiary. From 2008 to 2010, Mr. Worthington was Chief
Financial Officer of NetShelter Technology Media, an advertising and
media consulting firm, which provided services to over 160 leading
independent technology websites, with over 124 million unique visitors
per month. Prior to NetShelter, Mr. Worthington served as WaveRider
Communication Inc.'s Vice President and Chief Financial Officer for
eight years. Mr. Worthington has a Bachelor of Business Administration
from York University and is a Chartered Accountant.
"Scott has shown a great level of understanding, commitment, and passion
for the business since joining us as interim CFO in October 2010,"
stated Peter Tassiopoulos, CEO of Biosign. "His background and
experience in technology operations is extremely relevant. He is a
dynamic individual that will help us achieve our corporate goals."
About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems. Key
applications include intelligent systems for noninvasive monitoring of
common health risks associated with blood pressure, glucose, and
medication. The core technology combines measurement, analysis, and
rapid knowledge formation to support health monitoring across global
markets. The UFIT® medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness,
disease state evaluation & management, and remote patient monitoring.
For more information on Biosign, please visit www.biosign.com
This release contains forward-looking statements. Forward-looking
statements, without limitation, may contain the words believes,
expects, anticipates, estimates, intends, plans, or similar
expressions. Forward-looking statements are not guarantees of future
performance. They involve risks, uncertainties and assumptions and
Biosign's actual results could differ materially from those
anticipated. Forward looking statements are based on the opinions and
estimates of management at the date the statements are made, and are
subject to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from those
projected in the forward-looking statements. In the context of any
forward-looking information please refer to risk factors detailed in,
as well as other information contained in, Biosign's filings with
Canadian securities regulators (www.sedar.com).
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Biosign Technologies Inc.
For further information:
|Peter Tassiopoulos ||Alan S. Roemer, SVP|
|Biosign Technologies Inc. ||The Trout Group LLC|
|Phone: (416) 218-9800 ext. 234 ||Phone: 646 378-2900|
|Email: firstname.lastname@example.org ||Email: email@example.com|